Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 390
of 20Next
1:

A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes.

Schnakenberg E, Fabig KR, Stanulla M, Strobl N, Lustig M, Fabig N, Schloot W.

Environ Health. 2007 Feb 10;6:6.

PMID: 17291352 [PubMed - indexed for MEDLINE]

2:

Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.

Hirvonen A, Saarikoski ST, Linnainmaa K, Koskinen K, Husgafvel-Pursiainen K, Mattson K, Vainio H.

J Natl Cancer Inst. 1996 Dec 18;88(24):1853-6.

PMID: 8961976 [PubMed - indexed for MEDLINE]

3:

Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility.

Hengstler JG, Arand M, Herrero ME, Oesch F.

Recent Results Cancer Res. 1998;154:47-85. Review.

PMID: 10026993 [PubMed - indexed for MEDLINE]

4:

Genetic polymorphisms of phase II metabolic enzymes and lung cancer susceptibility in a population of Central South China.

Chen HC, Cao YF, Hu WX, Liu XF, Liu QX, Zhang J, Liu J.

Dis Markers. 2006;22(3):141-52.

PMID: 16788248 [PubMed - indexed for MEDLINE]

5:

Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.

Godschalk RW, Dallinga JW, Wikman H, Risch A, Kleinjans JC, Bartsch H, Van Schooten FJ.

Pharmacogenetics. 2001 Jul;11(5):389-98.

PMID: 11470992 [PubMed - indexed for MEDLINE]

6:

Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.

Kiss I, Németh A, Bogner B, Pajkos G, Orsós Z, Sándor J, Csejtey A, Faluhelyi Z, Rodler I, Ember I.

Anticancer Res. 2004 Nov-Dec;24(6):3965-70.

PMID: 15736440 [PubMed - indexed for MEDLINE]

7:

Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.

Thier R, Brüning T, Roos PH, Rihs HP, Golka K, Ko Y, Bolt HM.

Int J Hyg Environ Health. 2003 Jun;206(3):149-71. Review.

PMID: 12872524 [PubMed - indexed for MEDLINE]

8:

Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer.

Gates MA, Tworoger SS, Terry KL, Titus-Ernstoff L, Rosner B, De Vivo I, Cramer DW, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2436-44.

PMID: 18768514 [PubMed - indexed for MEDLINE]

9:

A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.

Spurdle AB, Chang JH, Byrnes GB, Chen X, Dite GS, McCredie MR, Giles GG, Southey MC, Chenevix-Trench G, Hopper JL.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):769-74.

PMID: 17416769 [PubMed - indexed for MEDLINE]

10:

Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North India.

Pandey SN, Jain M, Nigam P, Choudhuri G, Mittal B.

Biomarkers. 2006 May-Jun;11(3):250-61.

PMID: 16760134 [PubMed - indexed for MEDLINE]

11:

N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.

Lee KM, Park SK, Kim SU, Doll MA, Yoo KY, Ahn SH, Noh DY, Hirvonen A, Hein DW, Kang D.

Cancer Lett. 2003 Jul 10;196(2):179-86.

PMID: 12860276 [PubMed - indexed for MEDLINE]

12:

Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population.

Torkaman-Boutorabi A, Hoormand M, Naghdi N, Bakhshayesh M, Milanian I.

Clin Exp Pharmacol Physiol. 2007 Nov;34(11):1207-11.

PMID: 17880378 [PubMed - indexed for MEDLINE]

13:

Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.

Martínez C, Martín F, Fernández JM, García-Martín E, Sastre J, Díaz-Rubio M, Agúndez JA, Ladero JM.

Pharmacogenomics. 2006 Jul;7(5):711-8.

PMID: 16886896 [PubMed - indexed for MEDLINE]

14:

Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer.

Ferraz JM, Zinzindohoué F, Lecomte T, Cugnenc PH, Loriot MA, Beaune P, Stücker I, Berger A, Laurent-Puig P.

Int J Cancer. 2004 Jun 10;110(2):183-7.

PMID: 15069679 [PubMed - indexed for MEDLINE]

15:

Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma.

Tamer L, Calikoğlu M, Ates NA, Yildirim H, Ercan B, Saritas E, Unlü A, Atik U.

Respirology. 2004 Nov;9(4):493-8.

PMID: 15612961 [PubMed - indexed for MEDLINE]

16:

Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.

McGrath M, Michaud D, De Vivo I.

BMC Cancer. 2006 Oct 6;6:239.

PMID: 17026750 [PubMed - indexed for MEDLINE]

17:

Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer.

Sharma A, Mishra A, Das BC, Sardana S, Sharma JK.

Neoplasma. 2006;53(4):309-15.

PMID: 16830058 [PubMed - indexed for MEDLINE]

19:

GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.

Hung RJ, Boffetta P, Brennan P, Malaveille C, Hautefeuille A, Donato F, Gelatti U, Spaliviero M, Placidi D, Carta A, Scotto di Carlo A, Porru S.

Int J Cancer. 2004 Jul 1;110(4):598-604.

PMID: 15122594 [PubMed - indexed for MEDLINE]

20:

Genetic polymorphisms and chromosome damage.

Norppa H.

Int J Hyg Environ Health. 2001 Oct;204(1):31-8. Review.

PMID: 11725342 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 390
of 20Next